Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ginkgo Bioworks Holdings Inc (DNA) vs Hudbay Minerals Inc. Ordinary Shares (Canada) (HBM) Price & Performance

Ginkgo Bioworks Holdings IncTrade
Hudbay Minerals Inc. Ordinary Shares (Canada)Trade

Price performance (Past 24H)

Key statistics

Ginkgo Bioworks Holdings Inc vs Hudbay Minerals Inc. Ordinary Shares (Canada) — how do they compare? Ginkgo Bioworks Holdings Inc trades at $13 (market cap $763.64M), while Hudbay Minerals Inc. Ordinary Shares (Canada) trades at $26.12 (market cap $11.24B). The key difference: Hudbay Minerals Inc. Ordinary Shares (Canada) is far larger — about 14.7× Ginkgo Bioworks Holdings Inc's market cap, and Hudbay Minerals Inc. Ordinary Shares (Canada) pays a 0.11% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ginkgo Bioworks Holdings Inc for 7 Days and Hudbay Minerals Inc. Ordinary Shares (Canada) for 1 Days on average.

DNAHBM
Market Cap
$763.64M$11.24B
Volume
3,204,1774,316,374
Sector
HealthBasic Materials
52-Week High
$15.83$31.87
52-Week Low
$5.48$14.58
Typical Hold Time
7 Days1 Days
Enterprise Value
$865.59M$11.30B
Dividend Yield
—0.11%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks (DNA) trades at $13.00, up 13.34% today, with a bullish technical signal from moving averages. The company shows strong gross margins of 68.04% but remains unprofitable with a -219.6% net margin. Recent news includes a $17.5M ARPA-H subcontract for RNA medicine manufacturing and partnership expansions, though revenue declined to $132M in 2026.

DNA presents high risk with significant losses and cash burn, but analyst sentiment is divided with equal buy/sell ratings. Investment appeal hinges on future profitability from recent partnerships and government contracts, while current financials and negative cash flow pose substantial downside risk.

Hudbay Minerals Inc. Ordinary Shares (Canada)

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DNA
47% Buy53% Sell
Avg holding period · 7 Days
HBM

No sentiment data available yet.

Top news

Latest headlines on both assets

About Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.

Read more on DNA →

About Hudbay Minerals Inc. Ordinary Shares (Canada)

Hudbay Minerals is a mining company producing copper, gold, zinc, and other metals. Its operations are located in the Americas.

Read more on HBM →